Case report: Treatment of advanced CSF1-receptor associated leukoencephalopathy with hematopoietic stem cell transplant.

ALSP CSF1R-related leukoencephalopathy hematopoetic stem cell transplant microglia white matter dementia

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2023
Historique:
received: 10 02 2023
accepted: 25 04 2023
medline: 9 6 2023
pubmed: 9 6 2023
entrez: 9 6 2023
Statut: epublish

Résumé

CSF1 receptor-related leukoencephalopathy is a rare genetic disorder presenting with severe, adult-onset white matter dementia as one of the leading symptoms. Within the central nervous system, the affected CSF1-receptor is expressed exclusively in microglia cells. Growing evidence implicates that replacing the defective microglia with healthy donor cells through hematopoietic stem cell transplant might halt disease progression. Early initiation of that treatment is crucial to limit persistent disability. However, which patients are suitable for this treatment is not clear, and imaging biomarkers that specifically depict lasting structural damage are lacking. In this study, we report on two patients with CSF1R-related leukoencephalopathy in whom allogenic hematopoietic stem cell transplant at advanced disease stages led to clinical stabilization. We compare their disease course with that of two patients admitted in the same timeframe to our hospital, considered too late for treatment, and place our cases in context with the respective literature. We propose that the rate of clinical progression might be a suitable stratification measure for treatment amenability in patients. Furthermore, for the first time we evaluate [18F] florbetaben, a PET tracer known to bind to intact myelin, as a novel MRI-adjunct tool to image white matter damage in CSF1R-related leukoencephalopathy. In conclusion, our data add evidence for allogenic hematopoietic stem cell transplant as a promising treatment in CSF1R-related leukoencephalopathy patients with slow to moderate disease progression.

Identifiants

pubmed: 37292133
doi: 10.3389/fneur.2023.1163107
pmc: PMC10246448
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1163107

Informations de copyright

Copyright © 2023 Bergner, Schäfer, Vucinic, Schetschorke, Lier, Scherlach, Rullmann, Sabri, Classen, Platzbecker, Kühl, Barthel, Kühler and Franke.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Acta Neuropathol Commun. 2020 May 19;8(1):72
pubmed: 32430064
Eur J Neurol. 2017 Jan;24(1):37-45
pubmed: 27680516
Neurology. 2009 Jun 2;72(22):1953-9
pubmed: 19487654
Cold Spring Harb Perspect Biol. 2014 Jun 02;6(6):
pubmed: 24890514
Mov Disord. 2021 Dec;36(12):2901-2909
pubmed: 34329526
Brain. 2017 Apr 1;140(4):953-966
pubmed: 28375456
Neurology. 2013 Mar 12;80(11):1033-40
pubmed: 23408870
Int J Geriatr Psychiatry. 2004 Feb;19(2):136-43
pubmed: 14758579
Orphanet J Rare Dis. 2022 Feb 14;17(1):48
pubmed: 35164810
Neurology. 2018 Dec 11;91(24):1092-1104
pubmed: 30429277
BMC Neurol. 2015 Nov 25;15:243
pubmed: 26607782
J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1375-1376
pubmed: 31213485
JAMA Neurol. 2016 Dec 01;73(12):1433-1439
pubmed: 27749956
Brain Pathol. 2017 Nov;27(6):748-769
pubmed: 27608278
Trends Neurosci. 2016 Jun;39(6):378-393
pubmed: 27083478
Brain. 2016 Jun;139(Pt 6):1666-72
pubmed: 27190017
Br J Haematol. 2023 Apr;201(2):308-318
pubmed: 36573337
Brain. 2020 Feb 1;143(2):503-511
pubmed: 31840744
Neurology. 2018 Oct 16;91(16):755-757
pubmed: 30217938
Eur J Neurol. 2022 Jan;29(1):329-334
pubmed: 34541732
Neurology. 2012 Aug 7;79(6):566-74
pubmed: 22843259
Nat Rev Neurol. 2018 Feb;14(2):94-105
pubmed: 29302065
Pharmaceutics. 2022 Dec 12;14(12):
pubmed: 36559271
Mov Disord. 2022 May;37(5):1108-1109
pubmed: 35587623
Front Neurol. 2022 Feb 03;12:788168
pubmed: 35185751
Lancet Neurol. 2011 May;10(5):424-35
pubmed: 21481640
Eur J Neurol. 2018 Jan;25(1):142-147
pubmed: 28921817
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Leukoc Biol. 2020 Feb;107(2):205-219
pubmed: 31330095
Glia. 2021 Mar;69(3):779-791
pubmed: 33079443
J Inherit Metab Dis. 2019 Mar;42(2):313-324
pubmed: 30746707
Acta Psychiatr Scand Suppl. 1984;314:1-65
pubmed: 6595937
Mov Disord. 2022 Jul;37(7):1570-1572
pubmed: 35856733
Nat Genet. 2011 Dec 25;44(2):200-5
pubmed: 22197934
Neurol Neurochir Pol. 2021;55(3):322-324
pubmed: 33528831

Auteurs

Caroline G Bergner (CG)

Department of Neurology, Leukodystrophy Clinic, University of Leipzig Medical Center, Leipzig, Germany.

Lisa Schäfer (L)

Department of Neurology, Leukodystrophy Clinic, University of Leipzig Medical Center, Leipzig, Germany.

Vladan Vucinic (V)

Medical Department, Hematology, Cellular Therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany.

Birthe Schetschorke (B)

Medical Department, Hematology, Cellular Therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany.

Julia Lier (J)

Department of Neurology, Leukodystrophy Clinic, University of Leipzig Medical Center, Leipzig, Germany.

Cordula Scherlach (C)

Department of Radiology, University of Leipzig Medical Center, Leipzig, Germany.

Michael Rullmann (M)

Department Pediatric Oncology and Hematology, University of Leipzig Medical Center, Leipzig, Germany.

Osama Sabri (O)

Department Pediatric Oncology and Hematology, University of Leipzig Medical Center, Leipzig, Germany.

Joseph Classen (J)

Department of Neurology, Leukodystrophy Clinic, University of Leipzig Medical Center, Leipzig, Germany.

Uwe Platzbecker (U)

Medical Department, Hematology, Cellular Therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany.

Jörn-Sven Kühl (JS)

Department Pediatric Oncology and Hematology, University of Leipzig Medical Center, Leipzig, Germany.

Henryk Barthel (H)

Department of Nuclear Medicine, University of Leipzig Medical Center, Leipzig, Germany.

Wolfgang Köhler (W)

Department of Neurology, Leukodystrophy Clinic, University of Leipzig Medical Center, Leipzig, Germany.

Georg-Nikolaus Franke (GN)

Medical Department, Hematology, Cellular Therapies and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany.

Classifications MeSH